Literature DB >> 18474646

A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi.

Alan G Barbour1, Algimantas Jasinskas, Matthew A Kayala, D Huw Davies, Allen C Steere, Pierre Baldi, Philip L Felgner.   

Abstract

Humans and other animals with Lyme borreliosis produce antibodies to a number of components of the agent Borrelia burgdorferi, but a full accounting of the immunogens during natural infections has not been achieved. Employing a protein array produced in vitro from 1,292 DNA fragments representing approximately 80% of the genome, we compared the antibody reactivities of sera from patients with early or later Lyme borreliosis to the antibody reactivities of sera from controls. Overall, approximately 15% of the open reading frame (ORF) products (Orfs) of B. burgdorferi in the array detectably elicited an antibody response in humans with natural infections. Among the immunogens, 103 stood out on the basis of statistical criteria. The majority of these Orfs were also immunogenic with sera obtained from naturally infected Peromyscus leucopus mice, a major reservoir. The high-ranking set included several B. burgdorferi proteins hitherto unrecognized as immunogens, as well as several proteins that have been established as antigens. The high-ranking immunogens were more likely than nonreactive Orfs to have the following characteristics: (i) plasmid-encoded rather than chromosome-encoded proteins, (ii) a predicted lipoprotein, and (iii) a member of a paralogous family of proteins, notably the Bdr and Erp proteins. The newly discovered antigens included Orfs encoded by several ORFs of the lp36 linear plasmid, such as BBK07 and BBK19, and proteins of the flagellar apparatus, such as FliL. These results indicate that the majority of deduced proteins of B. burgdorferi do not elicit antibody responses during infection and that the limited sets of immunogens are similar for two different host species.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474646      PMCID: PMC2493225          DOI: 10.1128/IAI.00048-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  96 in total

1.  Identification of candidate antigen in Whipple's disease using a serological proteomic approach.

Authors:  Malgorzata Kowalczewska; Florence Fenollar; Daniel Lafitte; Didier Raoult
Journal:  Proteomics       Date:  2006-06       Impact factor: 3.984

2.  PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis.

Authors:  J L Gardy; M R Laird; F Chen; S Rey; C J Walsh; M Ester; F S L Brinkman
Journal:  Bioinformatics       Date:  2004-10-22       Impact factor: 6.937

3.  Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques.

Authors:  Suman Sundaresh; Denise L Doolan; Siddiqua Hirst; Yunxiang Mu; Berkay Unal; D Huw Davies; Philip L Felgner; Pierre Baldi
Journal:  Bioinformatics       Date:  2006-04-27       Impact factor: 6.937

Review 4.  Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis.

Authors:  Allen C Steere; Sheryn M Angelis
Journal:  Arthritis Rheum       Date:  2006-10

5.  Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteins.

Authors:  Andrew J Nowalk; Robert D Gilmore; James A Carroll
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

6.  Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development.

Authors:  Joseph P Connolly; Diego Comerci; Timothy G Alefantis; Alexander Walz; Marian Quan; Ryan Chafin; Paul Grewal; Cesar V Mujer; Rodolfo A Ugalde; Vito G DelVecchio
Journal:  Proteomics       Date:  2006-07       Impact factor: 3.984

Review 7.  The Lyme vaccine: a cautionary tale.

Authors:  L E Nigrovic; K M Thompson
Journal:  Epidemiol Infect       Date:  2006-08-08       Impact factor: 2.451

8.  Prospective study of coinfection in patients with erythema migrans.

Authors:  Allen C Steere; Gail McHugh; Carolin Suarez; Jason Hoitt; Nitin Damle; Vijay K Sikand
Journal:  Clin Infect Dis       Date:  2003-03-31       Impact factor: 9.079

9.  Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery.

Authors:  D Huw Davies; Xiaowu Liang; Jenny E Hernandez; Arlo Randall; Siddiqua Hirst; Yunxiang Mu; Kimberly M Romero; Toai T Nguyen; Mina Kalantari-Dehaghi; Shane Crotty; Pierre Baldi; Luis P Villarreal; Philip L Felgner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-12       Impact factor: 11.205

10.  In vivo transcriptome of Plasmodium falciparum reveals overexpression of transcripts that encode surface proteins.

Authors:  Johanna P Daily; Karine G Le Roch; Ousmane Sarr; Daouda Ndiaye; Amanda Lukens; Yingyao Zhou; Omar Ndir; Soulyemane Mboup; Ali Sultan; Elizabeth A Winzeler; Dyann F Wirth
Journal:  J Infect Dis       Date:  2005-02-28       Impact factor: 5.226

View more
  97 in total

1.  Identification of potential serodiagnostic and subunit vaccine antigens by antibody profiling of toxoplasmosis cases in Turkey.

Authors:  Li Liang; Mert Döşkaya; Silvia Juarez; Ayşe Caner; Algis Jasinskas; Xiaolin Tan; Bettina E Hajagos; Peter J Bradley; Metin Korkmaz; Yüksel Gürüz; Philip L Felgner; D Huw Davies
Journal:  Mol Cell Proteomics       Date:  2011-04-21       Impact factor: 5.911

2.  High-throughput prediction of protein antigenicity using protein microarray data.

Authors:  Christophe N Magnan; Michael Zeller; Matthew A Kayala; Adam Vigil; Arlo Randall; Philip L Felgner; Pierre Baldi
Journal:  Bioinformatics       Date:  2010-10-07       Impact factor: 6.937

Review 3.  Large screen approaches to identify novel malaria vaccine candidates.

Authors:  D Huw Davies; Patrick Duffy; Jean-Luc Bodmer; Philip L Felgner; Denise L Doolan
Journal:  Vaccine       Date:  2015-10-01       Impact factor: 3.641

Review 4.  Diversity of the Lyme Disease Spirochetes and its Influence on Immune Responses to Infection and Vaccination.

Authors:  Jerilyn R Izac; Richard T Marconi
Journal:  Vet Clin North Am Small Anim Pract       Date:  2019-04-06       Impact factor: 2.093

5.  Structure of decorin binding protein B from Borrelia burgdorferi and its interactions with glycosaminoglycans.

Authors:  Wei Feng; Xu Wang
Journal:  Biochim Biophys Acta       Date:  2015-08-11

6.  Immunodominant "asymptomatic" herpes simplex virus 1 and 2 protein antigens identified by probing whole-ORFome microarrays with serum antibodies from seropositive asymptomatic versus symptomatic individuals.

Authors:  Gargi Dasgupta; Aziz A Chentoufi; Mina Kalantari; Payam Falatoonzadeh; Sookhee Chun; Chang Hyun Lim; Philip L Felgner; D Huw Davies; Lbachir BenMohamed
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

7.  Rrp1, a cyclic-di-GMP-producing response regulator, is an important regulator of Borrelia burgdorferi core cellular functions.

Authors:  Elizabeth A Rogers; Darya Terekhova; Hong-Ming Zhang; Kelley M Hovis; Ira Schwartz; Richard T Marconi
Journal:  Mol Microbiol       Date:  2009-01-23       Impact factor: 3.501

8.  A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray.

Authors:  Peter D Crompton; Matthew A Kayala; Boubacar Traore; Kassoum Kayentao; Aissata Ongoiba; Greta E Weiss; Douglas M Molina; Chad R Burk; Michael Waisberg; Algis Jasinskas; Xiaolin Tan; Safiatou Doumbo; Didier Doumtabe; Younoussou Kone; David L Narum; Xiaowu Liang; Ogobara K Doumbo; Louis H Miller; Denise L Doolan; Pierre Baldi; Philip L Felgner; Susan K Pierce
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

9.  BBK07, a dominant in vivo antigen of Borrelia burgdorferi, is a potential marker for serodiagnosis of Lyme disease.

Authors:  Adam S Coleman; Utpal Pal
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

10.  Motility is crucial for the infectious life cycle of Borrelia burgdorferi.

Authors:  Syed Z Sultan; Akarsh Manne; Philip E Stewart; Aaron Bestor; Patricia A Rosa; Nyles W Charon; M A Motaleb
Journal:  Infect Immun       Date:  2013-03-25       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.